Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Securities - Tradable: 2022-2024

Historic Securities - Tradable for Praxis Precision Medicines (PRAX) over the last 2 years, with Dec 2024 value amounting to $254.2 million.

  • Praxis Precision Medicines' Securities - Tradable fell 1.19% to $239.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.6 million, marking a year-over-year decrease of 1.19%. This contributed to the annual value of $254.2 million for FY2024, which is N/A change from last year.
  • As of FY2024, Praxis Precision Medicines' Securities - Tradable stood at $254.2 million, which was up 553.36% from $38.9 million recorded in FY2022.
  • Praxis Precision Medicines' Securities - Tradable's 5-year high stood at $254.2 million during FY2024, with a 5-year trough of $38.9 million in FY2022.
  • In the last 2 years, Praxis Precision Medicines' Securities - Tradable had a median value of $146.5 million in 2022 and averaged $146.5 million.